USP Science & Research

USP Science & Research

制药业

20852,Rockville 7,293 位关注者

Building trust through rigorous science & standards that ensure quality.

关于我们

Scientific research and the expertise of our staff and volunteers are at the root of our work in advancing public health by ensuring the quality and safety of medicines, dietary supplements, and food ingredients. We are committed to rigorous science to help protect patient safety, build trust in our public quality standards setting, and improving the health of people around the world. We invite scientists, academics, regulatory professionals, healthcare practitioners, thought leaders, and others to follow this page to stay informed on our latest research publications and announcements on opportunities to serve as decision-makers and advisors on USP’s councils, committees, and panels.

网站
https://www.usp.org/our-science
所属行业
制药业
规模
1,001-5,000 人
总部
20852,Rockville
创立
1820
领域
nonprofit、standards setting和medicines quality standards

动态

  • USP Science & Research转发了

    查看Jayden Kwon的档案,图片

    Sr. Strategic Customer Development Manager at United States Pharmacopeia

    USP? ?? ??? ??? ?, 12?? ??? ? ???? 12? 12? ?? 10? 30?(?? ??)? ?????. E&L(Extractables and Leachable)? ?? ???? ?? ???, ? 1?? ?? ??? ???? ?? ??? ???? ?? ??? ??? ?????. Agenda, - USP E&L : ??, ???(Extractables and Leachable) ? ?? ???? ???? - USP? ?? ? ???(E&L) ?? ?? ?? ????? - ??? ??? ??? ?? ?? ? ??? ?? - USP-NF, ?? ?? ? USP? ??? ??? ?? - USP ?????? ??? ????? ?? ???? ???? : https://lnkd.in/gtUNwYET ???? : [email protected] The December edition of our monthly webinar series will be held on 12th Dec 2024. This live session will give you an update of USP Reference Standards as well as USP initiatives and activities in Asia Pacific. This month we will also discuss about USP initiatives and resources on Extractables and Leachables (E&Ls):For this month’s session you will be able to: ?Addressing regulatory concerns: Screening for extractables, leachables, and rubber oligomers. ?Explore USP's portfolio of Extractables and Leachables Analytical Reference Materials. ?Extractables and Leachables evaluations tailored to robust risk assessments ?Receive updates on the USP-NF, Reference Standards and other USP resourcesTo secure your spot today, kindly register at :? https://lnkd.in/gtUNwYET Feel free to leave your question during the registration and our Speaker might address it during the LIVE session. Please contact us at?[email protected]??if you have any questions. #USP #ExtractablesandLeachables #QualityHour #webcast #webinar

  • 查看USP Science & Research的公司主页,图片

    7,293 位关注者

    In today’s rapidly evolving and increasingly complex pharmaceutical landscape, new approaches are required for the development of quality standards. In response to this challenge, USP is taking an agile, iterative approach to standards development, inviting stakeholders to provide input earlier in the standards development process.? With our Emerging Standards program, emerging standards (potential future standards in the initial development phase) are shared through a dedicated website so our stakeholders like you can help shape them through discussion and exchange of information.? While emerging Standards are not official USP Standards, they are developmental ideas shared with the scientific community to stimulate early discussion and contributions. Input received at this early stage may significantly influence the standard development process. At our new site, it’s easier than ever to download, comment on, and share new emerging standards as they are published. For more information, please visit https://ow.ly/sJT850UbLsu or contact us directly at [email protected] #USPScience #EmergingStandards

    • 该图片无替代文字
  • 查看USP Science & Research的公司主页,图片

    7,293 位关注者

    ?? In case you missed it: The comment period for the below proposed General Chapters is open until November 30th! https://ow.ly/ihJS50U0MIa

    查看US Pharmacopeia的公司主页,图片

    166,025 位关注者

    Commenting open for the below proposed General Chapters revisions relevant to dietary supplements! <202> Identification of Fixed Oils by Thin-Layer Chromatography <2021> Microbial Enumeration Tests - Nutritional and Dietary Supplements <2022> Microbiological Procedures for Absence of Specified Microorganisms - Nutritional and Dietary Supplements Submit your feedback by November 30 to help shape USP quality standards: https://ow.ly/ihJS50U0MIa

    • 该图片无替代文字
  • USP Science & Research转发了

    查看US Pharmacopeia的公司主页,图片

    166,025 位关注者

    At USP, during #WorldStandardsWeek, and every day, we’re committed to helping stakeholders reduce the environmental impact of pharmaceutical manufacturing. Scroll ?? below to learn more about our work to develop US Pharmacopeia quality standards and solutions for a healthier, more sustainable world. #Repost to spread the word and join the conversation in honor of ANSI - American National Standards Institute's annual celebration of standards, culminating with today's #WorldStandardsDay. #SupplyChain #Sustainability #Standards

  • 查看USP Science &amp; Research的公司主页,图片

    7,293 位关注者

    Calling all dietary supplement, herbal medicines, and food ingredient quality experts looking for an opportunity to make a greater impact on #PublicHealth. We’re looking for you to join our global #USPExpertVolunteer network. This conference season, keep an eye out for US Pharmacopeia staff and current Volunteers at your next industry event. We’re ready and excited to share how you can contribute to quality standards and solutions for greater global access to safe, healthy, products worldwide. In the meantime, check out snapshots of where we’ve been so far and visit: Bit.ly/USPExpertVolunteer for more about serving with us in 2025-2030. #Supplement #HerbalMedicine #FoodSafety

    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
  • USP Science & Research转发了

    查看US Pharmacopeia的公司主页,图片

    166,025 位关注者

    Since the first biosimilar was approved in the U.S. in 2015, more than 60 biosimilars have entered the market, collectively saving healthcare systems an estimated $36 billion. On this year’s Global Biosimilars Week, we are pleased to announce the release of a 2.0 infographic on biosimilars quality, which we developed jointly with the FDA to serve as a resource for healthcare practitioners to better inform patients about the quality attributes of FDA-approved biosimilar products. Originally launched in 2022, this resource was designed to spark dialogue that will enable acceptance and adoption of these therapies. With the expansion of biosimilars, patients now have more access to quality treatment options for chronic and serious conditions, including cancer, diabetes, arthritis, and other chronic diseases. For more information, view the infographic below and share for awareness! #GlobalBiosimilarsWeek

  • 查看USP Science &amp; Research的公司主页,图片

    7,293 位关注者

    Last Chance! Don’t miss today’s virtual info session and find out how your pharmaceutical sciences expertise can empower you to amplify your impact on global #PublicHealth. As a #USPExpertVolunteer, you will contribute to US Pharmacopeiaquality standards and solutions that expand patient access to quality-assured medicines, accelerate the adoption of life-saving therapies, strengthen global supply chain resilience, and so much more. Register now: Bit.ly/EVRInfoSession and join us at NOON ET to learn more.

    • 该图片无替代文字
  • 查看USP Science &amp; Research的公司主页,图片

    7,293 位关注者

    #DYK? Your expertise in healthcare clinical informatics can enable greater availability and access to the world’s most relied-upon medicines. Right now, US Pharmacopeia is seeking experts like you to join our next volunteer cohort. Apply to serve as a #USPExpertVolunteer and help us develop, review, and revise quality standards and solutions for a healthier, safer tomorrow: Bit.ly/USPExpertVolunteer

    • 该图片无替代文字

关联主页

相似主页